Orchestra BioMed Holdings, Inc. logo

Orchestra BioMed Holdings, Inc. (OBIO)

Market Closed
5 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
4. 40
-0.28
-5.98%
$
295.87M Market Cap
- P/E Ratio
0% Div Yield
242,767 Volume
-1.6 Eps
$ 4.68
Previous Close
Day Range
4.38 4.7
Year Range
2.2 6.3
Want to track OBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Orchestra BioMed Holdings, Inc. logo
OBIO Orchestra BioMed Holdings, Inc.
12 Nov 2025
-
Cons. EPS
-
EPS
Orchestra BioMed Holdings, Inc. logo
OBIO Orchestra BioMed Holdings, Inc.
11 Nov 2025
-
Cons. EPS
-
EPS
Orchestra BioMed Holdings, Inc. logo
OBIO Orchestra BioMed Holdings, Inc.
11 Aug 2025
-
Cons. EPS
-
EPS
Orchestra BioMed Holdings, Inc. logo
OBIO Orchestra BioMed Holdings, Inc.
1 Apr 2025
-
Cons. EPS
-
EPS
Orchestra BioMed Holdings, Inc. logo
OBIO Orchestra BioMed Holdings, Inc.
13 Nov 2024
-
Cons. EPS
-
EPS
Orchestra BioMed Holdings, Inc. logo
OBIO Orchestra BioMed Holdings, Inc.
13 Aug 2024
-
Cons. EPS
-
EPS
Orchestra BioMed Holdings, Inc. logo
OBIO Orchestra BioMed Holdings, Inc.
14 May 2024
-
Cons. EPS
-
EPS
Orchestra BioMed Holdings, Inc. logo
OBIO Orchestra BioMed Holdings, Inc.
27 Mar 2024
-
Cons. EPS
-
EPS
Orchestra BioMed Holdings, Inc. logo
OBIO Orchestra BioMed Holdings, Inc.
13 Nov 2023
-
Cons. EPS
-
EPS

OBIO Earnings Reports FAQ

What is the earnings per share (EPS) for OBIO?

The current EPS is -1.6.

What is the company's earnings growth rate?

Orchestra BioMed Holdings, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Orchestra BioMed Holdings, Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Orchestra BioMed Holdings, Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for OBIO at this time, as Orchestra BioMed Holdings, Inc has no recent EPS data to calculate it.